Digital microfluidics (DMF) is an exciting technology for liquid handling, enabling low-volume droplet motion in electrode arrays, commonly mediated by voltage signals. Such technology allows for interesting applications in the field of molecular diagnostics, namely isothermal nucleic acid amplification for the detection of cancer biomarkers in low-volume samples. We developed a digital microfluidics platform capable of performing loop-mediated isothermal amplification (LAMP) of DNA while fitting under a fluorescence microscope, thus enabling a distinction between amplifying and non-amplifying samples, as well as monitoring the reaction progression. Our DNA amplification target is the cancer biomarker c-Myc, known as a “master regulator” due to its involvement in cell growth, proliferation and metabolism, which cumulatively intervenes in tumorigenesis. Specifically, the overexpression of c-Myc has been associated with as much as 40% of all human tumors. We successfully detected the amplification of the target DNA in under one hour with only 2 µL of total reaction volume. We also show the influence of mixing strategies when mixing LAMP reagents and DNA samples in our DMF platform, achieving uniform reagent distribution within reaction droplets, thus minimizing fluorescence signal fluctuations and maximizing reaction efficiency. Deep knowledge of mixing parameters on DMF is of utter relevance to the most recent enterprise in the group, which exploits DMF as a reagent mixing platform, a precursor to digital droplet PCR (ddPCR).
Author Contributions
B.J.C.: conceptualization, methodology, software, formal analysis, investigation, writing—original draft, writing—review & editing, visualization. B.V.: conceptualization, methodology. L.B.: software. H.Á.: funding acquisition, writing—review & editing. E.F.: funding acquisition, resources. R.M.: supervision, funding acquisition, resources. P.V.B.: conceptualization, supervision, project administration, funding acquisition, resources. R.I.: conceptualization, supervision, project administration, resources. All authors have read and agreed to the published version of the manuscript.
Funding
This work was financed by national funds from FCT—Fundação para a Ciência e a Tecnologia, I.P., in the scope of the project UIDP/04378/2020 and UIDB/04378/2020 of the Research Unit on Applied Molecular Biosciences-UCIBIO and the project LA/P/0140/2020 of the Associate Laboratory Institute for Health and Bioeconomy-i4HB. Additional funding was received from FCT under the scope of the project reference LA/P/0037/2020, UIDP/50025/2020 and UIDB/50025/2020 of the Associate Laboratory Institute of Nanostructures, Nanomodelling and Nanofabrication–i3N and under the frame of the project dPCR4FreeDNA–PTDC/BTM-SAL/31201/2017. Beatriz J. Coelho is grateful to FCT for the attribution of grant SFRH/BD/132904/2017 and grant COVID/BD/152453/2022.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
The data gathered in this study are available on request from the corresponding author.
Conflicts of Interest
The authors declare no conflict of interest.
| Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).